Exact Mass: 697.3450861999999

Exact Mass Matches: 697.3450861999999

Found 35 metabolites which its exact mass value is equals to given mass value 697.3450861999999, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Rifamycin

Rifamycin SV

C37H47NO12 (697.3098102)

A - Alimentary tract and metabolism > A07 - Antidiarrheals, intestinal antiinflammatory/antiinfective agents > A07A - Intestinal antiinfectives > A07AA - Antibiotics J - Antiinfectives for systemic use > J04 - Antimycobacterials > J04A - Drugs for treatment of tuberculosis > J04AB - Antibiotics D - Dermatologicals > D06 - Antibiotics and chemotherapeutics for dermatological use > D06A - Antibiotics for topical use A member of the class of rifamycins that exhibits antibiotic and antitubercular properties. S - Sensory organs > S01 - Ophthalmologicals > S01A - Antiinfectives > S01AA - Antibiotics D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D012294 - Rifamycins C254 - Anti-Infective Agent > C52588 - Antibacterial Agent > C280 - Antitubercular Agent S - Sensory organs > S02 - Otologicals > S02A - Antiinfectives > S02AA - Antiinfectives Same as: D02549

Bz-Ile-glu-gly-arg-pna

4-{[({4-carbamimidamido-1-[(4-nitrophenyl)carbamoyl]butyl}-C-hydroxycarbonimidoyl)methyl]-C-hydroxycarbonimidoyl}-4-[(1-hydroxy-2-{[hydroxy(phenyl)methylidene]amino}-3-methylpentylidene)amino]butanoate

C32H43N9O9 (697.3183588)

HEERQ

His-Glu-Glu-Arg-Gln

C27H43N11O11 (697.3143368)

Tas-108

C39H55NO10 (697.382577)

C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C1821 - Selective Estrogen Receptor Modulator C274 - Antineoplastic Agent > C129818 - Antineoplastic Hormonal/Endocrine Agent > C481 - Antiestrogen C147908 - Hormone Therapy Agent > C548 - Therapeutic Hormone > C483 - Therapeutic Estrogen D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones C147908 - Hormone Therapy Agent > C547 - Hormone Antagonist C1892 - Chemopreventive Agent

Betalutin

C30H47N7O10S (697.3104962)

D007155 - Immunologic Factors > D007136 - Immunoglobulins D007155 - Immunologic Factors > D000906 - Antibodies

25-acetylchaxamycin C

C37H47NO12 (697.3098102)

N-(2-aminophenyl)-N-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[[4-(trifluoromethyl)phenyl]methyl]amino]methyl]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-8-yl]heptanediamide

C37H46F3N5O5 (697.3450861999999)

CID 21775293

C37H55N5O6S (697.387285)

D009676 - Noxae > D011042 - Poisons > D008235 - Lyngbya Toxins D009676 - Noxae > D011042 - Poisons > D008387 - Marine Toxins

PC 20:4/7:3;O3

C35H56NO11P (697.3590796)

PC 20:5/7:2;O3

C35H56NO11P (697.3590796)

PC 27:7;O3

C35H56NO11P (697.3590796)

PE 18:4/12:3;O3

C35H56NO11P (697.3590796)

PE 22:4/8:3;O3

C35H56NO11P (697.3590796)

PE 22:5/8:2;O3

C35H56NO11P (697.3590796)

PE 30:7;O3

C35H56NO11P (697.3590796)

LNAPS 29:6;O

C35H56NO11P (697.3590796)

PS 18:4/11:2;O

C35H56NO11P (697.3590796)

PS 20:4/8:3;O2

C34H52NO12P (697.3226962)

PS 20:5/8:2;O2

C34H52NO12P (697.3226962)

PS 20:5/9:1;O

C35H56NO11P (697.3590796)

PS 28:7;O2

C34H52NO12P (697.3226962)

PS 29:6;O

C35H56NO11P (697.3590796)

ST 27:3;O8;HexNAc

C35H55NO13 (697.3673220000001)

QWF Peptide

C38H43N5O8 (697.3111478000001)

QWF Peptide (Compound 4a) is a substance P antagonist with an IC50 of 0.09 μM. QWF Peptide antagonizes the SP-induced contraction of isolated guinea pig trachea strips with an IC50 of 4.7 μM[1]. QWF Peptide (Compound 4a) is a substance P antagonist with an IC50 of 0.09 μM. QWF Peptide antagonizes the SP-induced contraction of isolated guinea pig trachea strips with an IC50 of 4.7 μM[1].